Takeda Launches New Pricing Program for Lung Cancer Drug Alunbrig
Takeda recently launched a value-based pricing program for its lung cancer drug Alunbrig.
Tag: lung cancer
All
Latest
All
Latest
Libtayo plus Chemo Significantly Improved Overall Survival in Advanced NSC Lung Cancer
Adding Libtayo to chemotherapy significantly improved median overall survival in advanced non-small cell lung cancer patients from 13 to 22 months, leading to a 29% reduction in the risk of death, compared to chemotherapy alone.
All
Latest
Lung Squamous Cell Carcinoma Tumors Reveal Therapeutic Alterations
A new study, reported in Oncotarget, found that unlike lung adenocarcinoma patients, there is no FDA-approved targeted-therapy likely to benefit lung squamous cell carcinoma patients.
FDA Clears Optellum’s Clinical Decision Support Software to Diagnose Lung Cancer
Optellum has received FDA 510(k) clearance for its Virtual Nodule Clinic, an AI-powered clinical decision software to support early diagnosis of lung cancer.
Read More
Deep Learning May Help Doctors Choose Better Lung Cancer Treatments
Physicians may one day use a machine learning model, called deep learning, to guide their treatment decisions for lung cancer patients
Read More
CT Scan Screening Catches Most Lung Cancers at Early Stage, Study Finds
A new study found that CT scan screenings may uncover lung cancer at an early stage, when it can still be removed, rather than continuing to grow without detection.
Read More
FDA Approves Medication to Prevent Chemo Damage in Lung Cancer
The FDA approved the new medication Cosela for injection to decrease the damage to the immune system and bone marrow from chemotherapy administered for lung cancer.
Read More
Can Saliva Be an Early Biomarker for Lung Cancer?
A study by UCLA School of Dentistry will use a Saliva Collection System from Spectrum Solutions LLC to determine whether saliva can be used for the early detection and analysis of lung cancer.
Read More
Air Pollution: Over Three Billion People Breathe Harmful Air Inside Their Own Homes
More than 3 billion people are exposed to air pollution within their own homes through cooking, heating and lighting with traditional fuels.
Read More
Merk’s Experimental Lung Cancer Drug Fails Trial
Merck KGaA’s experimental lung cancer treatment bintrafusp alfa failed in an early trial, the company recently announced.
Read More
FDA Approves Tagrisso for NSC Lung Cancer
The US FDA just approved AstraZeneca’s Tagrisso (osimertinib) as the first adjuvant treatment for patients with non-small cell lung cancer whose tumors have a specific type of genetic mutation.
Read More
Drugs Create Balancing Act for Patients with Non-small Cell Lung Cancer
Patients who receive a form of immunotherapy for non-small cell lung cancer may get more than one immune-related side effect, new research shows.
Read More
People of Color Face Greater Burden, Worse Lung Cancer Outcomes
People of color diagnosed with lung cancer face worse outcomes compared to white Americans, according to the American Lung Association’s third annual State of Lung Cancer report.
Read More
Critically Ill Cancer Patients at High Risk of Severe COVID-19, Mortality
More than two-thirds of cancer patients who acquired COVID-19 and went into acute respiratory failure required invasive mechanical ventilation and 39% of these patients died.
Read More
Novel Way to Tackle Asbestos-related Cancers
Gold nanotubes – tiny hollow cylinders one thousandth the width of a human hair – could be used to treat mesothelioma, new research shows.
Read More